Emulate is a Biotech company based in Boston, Massachusetts. It has raised $225M in total funding. Latest round: Series E.
Emulate funding overview
Emulate is a Biotech company based in Boston, Massachusetts. Emulate has raised $225M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series E announced in September 2021. The round record for Emulate runs through 2021; nothing later has been disclosed.
Emulate at a glance
Total raised
$225M
Latest round
Series E
Latest round date
September 2021
Industry
Biotech
Headquarters
Boston, Massachusetts
Frequently asked about Emulate funding
How much has Emulate raised?
Emulate has raised $225M in total disclosed funding across the rounds on record.
Who has invested in Emulate?
No investors are named on the public record for Emulate yet.
What was the latest Emulate funding round?
The most recent disclosed round is a Series E, announced in September 2021.
Where is Emulate based?
Emulate is based in Boston, Massachusetts.
What sector does Emulate operate in?
Emulate is tracked under Biotech from Boston, Massachusetts, with $225M in disclosed funding.
When did Emulate last raise?
The last disclosed Emulate round closed in September 2021 at Series E.
We update the Emulate record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in Boston and their backers are listed below.
